Efficacy and safety of early treatment with Adalimumab in patients with Psoriatic Arthritis
Latest Information Update: 19 Dec 2017
Price :
$35 *
At a glance
- Drugs Adalimumab (Primary)
- Indications Psoriatic arthritis
- Focus Therapeutic Use
- 19 Dec 2017 New trial record
- 08 Nov 2017 Results presented at the 81st American College of Rheumatology and the 52nd Association of Rheumatology Health Professionals Annual Scientific Meeting